Insider · CIK 0001898490
Rhonda Farnum
Files at TBPH (Theravance Biopharma, Inc.). First filing Nov 13, 2024, latest Sep 17, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
TBPH: Theravance Biopharma, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 8Weak | Theravance Biopharma, Inc. | $227k 13,314 shares | -6% | - | |
| 1Weak | Theravance Biopharma, Inc. | $36k 4,000 shares | -1% | - | |
| 21Weak | TBPHsell Theravance Biopharma, Inc. | $36k 4,000 shares | -1% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | DDisposition to issuer Ordinary Shares | -124,414 | - | - | 89,062 | 18 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | DDisposition to issuer Ordinary Shares | -89,062 | - | - | 0 | 18 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | DDisposition to issuer Share Option (Right to Buy)derivative | -150,000 | - | - | 0 | 18 d ago |
| Sep 15, 2026 | TBPH Theravance Biopharma, Inc. | SOpen-market sale Ordinary Shares10b5-1 | -3,329 | $17.03 | $57k | 223,461 | 25 d ago |
| Sep 15, 2026 | TBPH Theravance Biopharma, Inc. | SOpen-market sale Ordinary Shares10b5-1 | -3,328 | $17.03 | $57k | 220,133 | 25 d ago |
| Sep 15, 2026 | TBPH Theravance Biopharma, Inc. | SOpen-market sale Ordinary Shares10b5-1 | -6,657 | $17.03 | $113k | 213,476 | 25 d ago |
| Feb 28, 2025 | TBPH Theravance Biopharma, Inc. | AGrant or award Ordinary Shares | +75,000 | $0.00 | $0 | 374,038 | Mar 4, 2025 |
| Feb 10, 2025 | TBPH Theravance Biopharma, Inc. | AGrant or award Ordinary Shares | +5,283 | $0.00 | $0 | 314,848 | Feb 24, 2025 |
| Feb 20, 2025 | TBPH Theravance Biopharma, Inc. | FTax withholding Ordinary Shares | -15,810 | $9.66 | $153k | 299,038 | Feb 24, 2025 |
| Jan 21, 2025 | TBPH Theravance Biopharma, Inc. | SOpen-market sale Ordinary Shares10b5-1 | -4,000 | $9.00 | $36k | 309,565 | Jan 23, 2025 |
| Nov 20, 2024 | TBPH Theravance Biopharma, Inc. | FTax withholding Ordinary Shares | -9,178 | $9.97 | $92k | 313,565 | Nov 22, 2024 |
| Nov 11, 2024 | TBPH Theravance Biopharma, Inc. | SOpen-market sale Ordinary Shares | -4,000 | $9.00 | $36k | 322,743 | Nov 13, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.